--- Query Results --- | |||
Program: | Genetics and Genomics | ||
Test Name: | Neurofibromatosis Type 2 (Gene: NF2) | ||
Test Code: | CERNER: MDLBL-;APPEND TEST NAME AND SPECIMEN TYPE | ||
Performing Site: | Alberta Children's Hospital | ||
Performing Dept: | Molecular Diagnostics | ||
TAT: | Up to 16 weeks | ||
Preferred Tube/Container: | See Specimen Requirements | ||
Specimen Requirements: | For Blood Specimen (peripheral or cord blood) For Prenatal Specimens Submit in a sterile 15 mL or 50 mL polypropylene centrifuge tube or in a plain sterile tube with screw cap NOTE: A maternal blood sample (as outlined above) must be collected for maternal cell contamination studies. For Other Tissue Specimens placed in transport media. For Extracted DNA | ||
Min. Sample Required: | If unable to collect the minimum as per specimen requirements, contact the laboratory. | ||
Specimen Processing: | Unopened dedicated tubes (do not share) are required for Molecular Diagnostic Laboratory testing. Do not spin or aliquot specimens. For all specimen types (except frozen tissue) store specimens at ambient temperature if being shipped on same day of collection (preferred). Specimens can be stored at 4 - 8oC if shipping is delayed. Store frozen tissue specimens at -20oC to -80oC. | ||
Specimen Handling: | Transport all specimen types (except frozen tissue) at ambient temperature. Specimens must not freeze in transit. Transport frozen tissue specimens with adequate amounts of dry ice to keep specimen frozen. Specimens must not thaw in transport. Specimens, with completed requisitions, should be received by the Molecular Diagnostic Laboratory: Ship specimens to Molecular Diagnostic Laboratory at Alberta Children’s Hospital Room B0-020. | ||
Requisition/Form: | All requests MUST be submitted on a Molecular Diagnostic Laboratory Cancer and Endocrine Next Generation Sequencing Requisition. Please ensure all required information, including patient's clinical history/indication, is provided on the requisition. | ||
Order Restrictions: | Genetics | ||
Gene: | NF2 | ||
Method: | Next Generation Sequencing | ||
Method Details: | Genomic DNA is sequenced on a NGS instrument. NGS detects nucleotide substitutions, small insertions and deletions, and copy number variants. Sanger sequencing is used to confirm all variants with clinical or uncertain significance and to analyze regions with <90% technical sensitivity by NGS. Additional deletion/duplication testing may be performed by a variety of methods, including, but not limited to: multiplex ligation-dependent probe amplification and quantitative PCR. | ||
Reference Interval: | Interpretation provided on report. | ||
Comments: | For additional information refer to Genetic Laboratory Services webpage or contact MDL South at ACH at 403-955-7397 (phn) or 403-955-7624 (fax). | ||
Last Updated On: | Monday, June 18, 2018 | ||
Date of Last Review: | Jan 2 2018 12:00AM | ||